Accreditations and Registrations

Registered with the Food and Drug Administration (FDA)
The Food and Drug Administration (FDA) has already taken initial steps to regulate the field of cord blood banking. We welcome the regulation because being inspected by the FDA provides us with the good housekeeping seal of approval. It gives you the quality assurance you need in order to know that you have chosen a credible organization with which to store your child's cord blood. We are proud to be among the first cord blood banks to have registered with the FDA.

Licensed with PharmaStem under U.S. Patents 5,004,681, 5,192,553, 6,461,645, 6,569,427 and 6,605,275
NECBB is among the first cord blood banks to enter into a licensing agreement with PharmaStem Therapeutics, Inc., the holder of five U.S. patents related to processing umbilical cord blood used by most cord blood banks. The license ensures that your baby's cells are legally protected. Cord blood banks without a PharmaStem license risk being found guilty of patent infringement, jeopardizing the safety of the cells they are storing. Our PharmaStem license also protects doctors, midwives and hospitals as well from the threat of legal penalties.

Our laboratory has a federal CLIA License
CMS regulates all laboratory testing performed on humans in the U.S. through the Clinical Laboratory Improvement Amendments (CLIA). The objective of the CLIA
(Lic. #: 22D0725005) program is to ensure quality laboratory testing.

Licensed by the States of New York, California and Massachusetts
Our state of the art laboratory is fully compliant with both Federal and State clinical laboratory regulations for processing your child's cord blood. The States of Massachusetts (Lic. # 2337), California (Lic. # CNC_80400) and New York (Lic. # SC112) have issued regulations regarding the cord blood banking, and we are licensed by all three states.